Trinity Biotech (TRIB)
(Delayed Data from NSDQ)
$1.65 USD
-0.01 (-0.60%)
Updated May 31, 2024 03:59 PM ET
After-Market: $1.65 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth NA Momentum NA VGM
Brokerage Reports
Trinity Biotech PLC [TRIB]
Reports for Purchase
Showing records 41 - 60 ( 102 total )
Company: Trinity Biotech PLC
Industry: Medical - Products
3Q 2014: Quarterly Medical Technology Trading & Acquisition Valuation Update
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Trinity Biotech PLC
Industry: Medical - Products
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Trinity Biotech PLC
Industry: Medical - Products
Company: Trinity Biotech PLC
Industry: Medical - Products
2Q 2014: Quarterly Medical Technology Trading & Acquisition Valuation UpdateThis report contains brief updates on the following: ALGN, BABY, ETRM, EXAS, ICUI, LMAT, MASI, NSPH, TEAR, TRIB, UPI, VOLC. These companies are covered in more detail in separate Daily Notes and/or Company Reports.
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Trinity Biotech PLC
Industry: Medical - Products
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Trinity Biotech PLC
Industry: Medical - Products
Upgrading to Buy on Cardiac Opportunity - PT to $30
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Trinity Biotech PLC
Industry: Medical - Products
Healthcare: 1Q 2014: Quarterly Medical Technology Trading & Acquisition Valuation Update
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Trinity Biotech PLC
Industry: Medical - Products
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Trinity Biotech PLC
Industry: Medical - Products
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Trinity Biotech PLC
Industry: Medical - Products
4Q Soft, But Cardiac Data Encouraging - PT to $28
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Trinity Biotech PLC
Industry: Medical - Products
4Q 2013: Quarterly Medical Technology Trading & Acquisition Update
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Trinity Biotech PLC
Industry: Medical - Products
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Trinity Biotech PLC
Industry: Medical - Products
Company: Trinity Biotech PLC
Industry: Medical - Products
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Trinity Biotech PLC
Industry: Medical - Products
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Trinity Biotech PLC
Industry: Medical - Products
3Q Preview: Expecting Inline Q; Progressing w/ Fiomi, Immco Integration
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Trinity Biotech PLC
Industry: Medical - Products
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Trinity Biotech PLC
Industry: Medical - Products
Company: Trinity Biotech PLC
Industry: Medical - Products
Soft 2Q Offset by Immco Acquisition; Maintain Neutral
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Trinity Biotech PLC
Industry: Medical - Products
2Q Preview: Expecting Relatively Inline 2Q; Looking for Fiomi Update
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C